There is currently no text in this page. You can search for this page title in other pages, or search the related logs, but you do not have permission to create this page.
Category:C07K16/30
Subcategories
This category has the following 17 subcategories, out of 17 total.
A
B
E
G
H
J
L
W
Y
Pages in category "C07K16/30"
The following 21 pages are in this category, out of 21 total.
1
- 18359569. LDL RECEPTOR-DIRECTED BISPECIFIC BINDING AGENT-LIGAND FUSIONS FOR THE DEGRADATION OF TARGET PROTEINS simplified abstract (THE REGENTS OF THE UNIVERSITY OF CALIFORNIA)
- 18550914. METHODS FOR TREATING GYNECOLOGIC CANCER USING COMBINATION THERAPY WITH ANTI-MUC16 x CD3 MULTISPECIFIC ANTIBODIES AND VEGF INHIBITORS simplified abstract (The General Hospital Corporation)
- 18552131. HYBRID RECEPTORS WITH MULTIPLE TRANSCRIPTIONAL REGULATORS simplified abstract (The Regents of the University of California)
- 18552141. SYNTHETIC INTERMEMBRANE PROTEOLYSIS RECEPTORS FOR CUSTOM ANTIGEN-INDUCED TRANSCRIPTIONAL REGULATION simplified abstract (The Regents of the University of California)
- 18609414. HUMAN MESOTHELIN CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF (Novartis AG)
- 18609414. HUMAN MESOTHELIN CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF (The Trustees of the University of Pennsylvania)
- 18627108. WNT SIGNALING AGONIST MOLECULES (University of Washington)
- 18680465. ANTIBODY MOLECULES TO PD-1 AND USES THEREOF (President and Fellows of Harvard College)
- 18834037. NATURAL KILLER T-CELLS AND METHODS OF USING THE SAME (The University of North Carolina at Chapel Hill)
- 18883719. COMPOSITIONS AND METHODS FOR TARGETED IMMUNOMODULATORY ANTIBODIES AND FUSION PROTEINS (The Johns Hopkins University)
- 18914687. PERTUZUMAB VARIANTS AND EVALUATION THEREOF (Genentech, Inc.)
- 18956269. METHODS OF TREATING CANCERS USING PD-1 AXIS BINDING ANTAGONISTS AND TAXANES (Genentech, Inc.)
- 18999227. METHODS FOR TREATING NEUROBLASTOMA (ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA)
B
T
- TECHNOPHAGE, INVESTIGAÇÃO E DESENVOLVIMENTO EM BIOTECNOLOGIA, S.A. (20240245800). HIGHLY SPECIFIC RABBIT SINGLE -DOMAIN ANTIBODIES FOR DRUG DELIVERY IN IMMUNOTHERAPY APPLICATIONS simplified abstract
- The regents of the university of california (20240299545). HYBRID RECEPTORS WITH MULTIPLE TRANSCRIPTIONAL REGULATORS simplified abstract
- The Regents of the University of California patent applications on September 12th, 2024